Astreas Shines at TechCrunch Disrupt, Biotech IPOs Surge

Astreas, an AI-powered human performance startup, is set to showcase its innovative solutions at TechCrunch Disrupt 2024. Meanwhile, three biotech startups are targeting up to $400 million in IPOs, capitalizing on a booming healthcare market. Additionally, 35 Indian startups presented their groundbreaking ideas at a NASSCOM event in Silicon Valley, while Cookie Finance raises $4.1 million to support social media content creators with tailored financial services. Join us as we explore the latest trends in startup innovation and investment opportunities.

Sources:
https://www.newswire.com/news/astreas-selected-to-participate-in-startup-battlefield-200-at-22435803
https://wincountry.com/2024/10/07/three-startups-target-up-to-400-million-as-biotech-ipos-gain-traction/
https://indicanews.com/35-startups-from-nasscom-present-to-silicon-valley-audience/
https://richmondbizsense.com/2024/10/07/accounting-startup-aimed-at-social-media-content-creators-closes-on-4m-capital-raise/

Outline:
(00:00:00) Introduction
(00:00:45) Astreas Selected to Participate in Startup Battlefield 200 at TechCrunch Disrupt 2024
(00:03:41) Three startups target up to $400 million as biotech IPOs gain traction
(00:06:34) 35 startups from NASSCOM present to Silicon Valley audience
(00:09:19) Accounting startup aimed at social media content creators closes on $4M capital raise